AU8510398A - Fibrinogen receptor antagonists - Google Patents

Fibrinogen receptor antagonists

Info

Publication number
AU8510398A
AU8510398A AU85103/98A AU8510398A AU8510398A AU 8510398 A AU8510398 A AU 8510398A AU 85103/98 A AU85103/98 A AU 85103/98A AU 8510398 A AU8510398 A AU 8510398A AU 8510398 A AU8510398 A AU 8510398A
Authority
AU
Australia
Prior art keywords
receptor antagonists
fibrinogen receptor
fibrinogen
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85103/98A
Other languages
English (en)
Inventor
Dirk Heerding
James M. Samanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU8510398A publication Critical patent/AU8510398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU85103/98A 1997-07-25 1998-07-23 Fibrinogen receptor antagonists Abandoned AU8510398A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5378897P 1997-07-25 1997-07-25
US60053788 1997-07-25
US6354597P 1997-10-28 1997-10-28
US60063545 1997-10-28
PCT/US1998/015288 WO1999004796A1 (en) 1997-07-25 1998-07-23 Fibrinogen receptor antagonists

Publications (1)

Publication Number Publication Date
AU8510398A true AU8510398A (en) 1999-02-16

Family

ID=26732245

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85103/98A Abandoned AU8510398A (en) 1997-07-25 1998-07-23 Fibrinogen receptor antagonists

Country Status (6)

Country Link
EP (1) EP1001777A4 (de)
JP (1) JP2002509547A (de)
AU (1) AU8510398A (de)
CA (1) CA2297909A1 (de)
CO (1) CO4970784A1 (de)
WO (1) WO1999004796A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6069143A (en) * 1994-12-20 2000-05-30 Smithkline Beecham Corporation Fibrinogen receptor antagonists

Also Published As

Publication number Publication date
WO1999004796A1 (en) 1999-02-04
JP2002509547A (ja) 2002-03-26
EP1001777A4 (de) 2002-10-09
CO4970784A1 (es) 2000-11-07
CA2297909A1 (en) 1999-02-04
EP1001777A1 (de) 2000-05-24

Similar Documents

Publication Publication Date Title
AU3579897A (en) Fibrinogen receptor antagonists
AU1441695A (en) Fibrinogen receptor antagonists
EP0810994A4 (de) Fibrinogen-rezeptor-antagonisten
AU7692996A (en) Receptor antagonists
AU4746297A (en) Vitronectin receptor antagonists
AU2143295A (en) Neurokinin receptor antagonists
AU8689798A (en) Integrin receptor antagonists
EP0866705A4 (de) Fibrinogenrezeptorantagonisten
EP0885205A4 (de) Fibrinogen-rezeptor-antagonisten
AU3503797A (en) Fibrinogen receptor antagonist prodrugs
AU2242197A (en) Benzimidzolyl neuropeptide y receptor antagonists
EP0885213A4 (de) Fibrinogenrezeptor antagonisten
AU8673198A (en) Il-8 receptor antagonists
EP0796098A4 (de) Fibrinogenrezeptor-antagonisten
IL135797A0 (en) Thrombin receptor antagonists
AU1230795A (en) Adhesion receptor antagonists
EP0801650A4 (de) Fibrinogenrezeptor-antagonisten
AU9185598A (en) Novel neuropeptide y receptor antagonists
AU1296899A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
EP0794779A4 (de) Fibrinogenrezeptorantagonisten
AU5764298A (en) Tachykinin antagonists
AU6435098A (en) Il-8 receptor antagonists
AU1735200A (en) Novel isoxazoline fibrinogen receptor antagonists
AU3503397A (en) Fibrinogen receptor antagonist prodrugs
GB9515852D0 (en) Fibrinogen receptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase